Sanofi SA
SWB:SNW2
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Sanofi SA
SWB:SNW2
|
FR |
|
T
|
Tenet Healthcare Corp
F:THC1
|
US |
|
Roche Holding AG
OTC:RHHVF
|
CH |
|
Christian Dior SE
PAR:CDI
|
FR |
|
N
|
Nike Inc
XMUN:NKE
|
US |
|
Netflix Inc
NASDAQ:NFLX
|
US |
|
Shimano Inc
F:SHM
|
JP |
|
Vestas Wind Systems A/S
SIX:VWS
|
DK |
|
E
|
Estee Lauder Companies Inc
SWB:ELAA
|
US |
Wall St Price Targets
SNW2 Price Targets Summary
Sanofi SA
According to Wall Street analysts, the average 1-year price target for SNW2 is 48.64 EUR with a low forecast of 28.8 EUR and a high forecast of 58.84 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is SNW2's stock price target?
Price Target
48.64
EUR
According to Wall Street analysts, the average 1-year price target for SNW2 is 48.64 EUR with a low forecast of 28.8 EUR and a high forecast of 58.84 EUR.
What is the Revenue forecast for Sanofi SA?
Projected CAGR
5%
Over the last 13 years, the compound annual growth rate for Revenue has been 2%. The projected CAGR for the next 3 years is 5%.
What is the Gross Profit forecast for Sanofi SA?
Projected CAGR
7%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 2%. The projected CAGR for the next 3 years is 7%.
What is the Operating Income forecast for Sanofi SA?
Projected CAGR
14%
Over the last 13 years, the compound annual growth rate for Operating Income has been 2%. The projected CAGR for the next 3 years is 14%.
What is the Pre-Tax Income forecast for Sanofi SA?
Projected CAGR
34%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 1%. The projected CAGR for the next 3 years is 34%.
What is the Net Income forecast for Sanofi SA?
Projected CAGR
16%
Over the last 13 years, the compound annual growth rate for Net Income has been 4%. The projected CAGR for the next 3 years is 16%.
